Mondher Mahjoubi was appointed Chief Executive Officer and Chairman of the Executive Board on December 30, 2016.
Prior to joining Innate Pharma, Dr. Mahjoubi led the Oncology Therapy area at AstraZeneca beginning in November 2013 and was Oncology Global Manager from August 2016. In that role, he had direct responsibility for oncology global medical affairs and United States medical affairs. Prior to AstraZeneca, he was the Senior Vice President of global product strategy in oncology at Genentech from 2010 to 2013 and he previously held positions in marketing and medical affairs for Roche, Mayne Pharma, Sanofi-Aventis and Rhone Poulenc Rorer.
Dr. Mahjoubi holds a M.D. from the University of Tunis and certifications in Medical Oncology from the University of Tunis and University of Paris Sud and in Clinical Research and Methodology from the University of Lariboisiere-Saint Louis. He is trained as a medical oncologist and is a member of the American Society of Clinical Oncology and European Society of Medical Oncology.